Rx only · Capsule, Extended Release · Oral
Dexmethylphenidate Hydrochloride
Brands: Focalin Xr · Dexmethylphenidate Hydrochloride
8 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US78 NDCs
8 active makers
8 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 66 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$2.611
Latest avg · Jul 22, 2026
-45%
Since Jul 23, 2025
8
Active US suppliers
39%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
726K
Rx · 2026 Q1
21.9M
Units dispensed
+10%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it8 active · 1 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Sandoz Inc | unknown | 16 | SUPPLYING |
| Bryant Ranch Prepack | repackager | 15 | SUPPLYING |
| Par Health USA, LLC | unknown | 10 | SUPPLYING |
| Lannett Company, Inc. | unknown | 8 | SUPPLYING |
| Teva Pharmaceuticals USA, Inc. | unknown | 8 | SUPPLYING |
| Granules Pharmaceuticals Inc | unknown | 8 | SUPPLYING |
| Camber Pharmaceuticals, Inc. | unknown | 8 | SUPPLYING |
| Amneal Pharmaceuticals of New York LLC | unknown | 7 | SUPPLYING |
| Novartis Pharmaceuticals Corporation | unknown | 6 | EXITED 2026 |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Jun 1, 2026RECALLRecall (Class III): Focalin XR (dexmethylphenidate HCl) 5 mg, 30 extended-release capsules per bottle, Rx only, Manufactured by Societal CD…
Labeling: Incorrect or Missing Lot and/or Exp Date — Recalling firm: Sandoz Inc — U.S. Nationwide
Pill